BC
IDXX icon

Bayforest Capital’s Idexx Laboratories IDXX Stock Holding History

Bayforest Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
223
+36
+19% +$20.2K 0.11% 372
2026
Q1 		$105K Sell
187
-12
-6% -$7.7K 0.12% 342
2025
Q4 		$135K Sell
199
-339
-63% -$231K 0.1% 395
2025
Q3 		$344K Buy
538
+306
+132% +$186K 0.16% 253
2025
Q2 		$124K Sell
232
-264
-53% -$126K 0.05% 442
2025
Q1 		$208K Buy
496
+216
+77% +$93.8K 0.09% 381
2024
Q4 		$116K Buy
+280
New +$123K 0.15% 278

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bayforest Capital's IDXX Position: Q2 2026 in Review

Bayforest Capital increased its Idexx Laboratories (IDXX) stake by 19% in Q2 2026, buying an estimated $20.2K and bringing the position to 223 shares worth $117K. The position accounts for 0.11% of the portfolio, ranked #372.

Bayforest Capital first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $344K in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bayforest Capital held 223 shares of Idexx Laboratories worth $117K as of Q2 2026.
  • Bayforest Capital bought 36 Idexx Laboratories shares in Q2 2026, an estimated $20.2K.
  • Idexx Laboratories made up 0.11% of Bayforest Capital's portfolio in Q2 2026, its #372 holding.
  • Bayforest Capital first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's Idexx Laboratories position peaked at $344K in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.